# Healthcare Innovation

Shenzhen’s Bio-Blueprint: The ‘Cell Ten Articles’ and China’s Quest for Genomic Leadership

Shenzhen has launched a comprehensive policy package known as the 'Cell Ten Articles' to accelerate the growth of its cell and gene therapy industries. The initiative is a key part of China's strategic shift toward high-end biotechnology as a pillar for future economic growth and national security.